Zyden Gentec Ltd. benchmarking: Perfomance to industry peers

Financial

	Zyden Gentec	Hemo Organic	Ganga Pharma.
Operational Metrics
Financials
5 yr Average ROE	-24.76 %	-361.35 %	0.71 %
5yr average Equity Multiplier	2.0	-1.56	1.37
5yr Average Asset Turnover Ratio	0.21	0.14	0.31
5yr Avg Net Profit Margin	-137.59 %	-763.22 %	1.72 %
Price to Book	n/a	0.0	0.98
P/E	n/a	40.27	89.76
5yr Avg Cash Conversion Cycle	785.76 Days	100.48 Days	237.0 Days
Inventory Days	134.34 Days	406.93 Days	165.67 Days
Days Receivable	803.05 Days	196.55 Days	126.89 Days
Days Payable	421.99 Days	2776.86 Days	119.78 Days
5yr Average Interest Coverage Ratio	-2.08	-250.54	1.32
5yr Avg ROCE	-6.92 %	37.52 %	3.77 %
5yr Avg Operating Profit Margin	-95.87 %	-745.72 %	0.19 %
5 yr average Debt to Equity	0.68	-0.73	0.28
5yr CAGR Net Profit	-1.66 %	n/a	31.95 %
5yr Average Return on Assets	-15.88 %	-33.34 %	0.53 %
Shareholdings
Promoter Holding	0.0	16.85 %	50.91 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	-17.28 %	0.0	-15.8 %
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0